Adalimumab biosimilar ABP 501 is equally effective and safe in long-term management of inflammatory bowel diseases patients when used as first biologic treatment or as replace of the ADA originator…

Overview of attention for article published in Frontiers in Gastroenterology, October 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 1 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 1 citation of this research output.

1

The most recent citing publication is shown below. View this citation on Dimensions.

Clinical use of biologics for Crohn’s disease in adults: lessons learned from real-world studies

Article in Expert Opinion on Biological Therapy (February 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.